You are here: Home / Products / Cosmetic Ingredients / Hydroxypropyl Beta Cyclodextrin Cosmetic Solubility Enhancer Ingredients

Hydroxypropyl Beta Cyclodextrin Cosmetic Solubility Enhancer Ingredients

Manufactured under strict GMP conditions in our 2,000㎡ dedicated cleanroom, our Injection Grade Hydroxypropyl Beta Cyclodextrin (HP-β-CD) sets the industry standard for pharmaceutical excipients. With FDA DMF registration (#030168) and full compliance with USP, EP, and CP monographs, this product features ultra-low betadex residue (≤1.5%) and propylene oxide levels below 0.0001%. It dramatically improves solubility of poorly water-soluble drugs—up to hundreds of times—while enhancing bioavailability and reducing drug toxicity. Ideal for injections, mucosal delivery systems, and targeted drug formulations requiring the highest purity standards.
Availability:
Quantity:
facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button

Hydroxypropyl Beta Cyclodextrin (HP-β-CD) is a hydroxyalkylated derivative of beta-cyclodextrin, produced via controlled substitution of hydroxyl groups with hydroxypropyl moieties. As an injection-grade excipient, this compound functions as a solubilizing agent for poorly water-soluble active pharmaceutical ingredients (APIs). The molecular structure features a hydrophobic internal cavity and a hydrophilic external surface, enabling inclusion complex formation with lipophilic molecules.

This product is manufactured under GMP conditions in a dedicated production facility, with FDA DMF registration (#030168) on file. It complies with USP, EP, and CP monograph specifications, with a betadex residual content of 1.5% maximum and propylene oxide levels below 0.0001%.

HP-β-CD

HP-β-CD Technical Specifications and Quality Parameters

Test Item

Specification (USP-NF 2023)

Appearance

White or almost white, amorphous or crystalline powder. Freely soluble in water and in propylene glycol

Molar substitution

0.40-1.50

Betadex

≤1.5%

Propylene glycol

≤2.5%

Any other single impurity

≤0.25%

Total impurities (excluding betadex and propylene glycol)

≤1.0%

Propylene oxide

≤0.0001%

Loss on drying

≤10.0%

Clarity of solution

1.0 g/2 mL water solution is clear and transparent

Conductivity

≤200 μS/cm

Bacterial Endotoxins

≤10 EU/g

Total aerobic microbial count

≤1000 cfu/g

Total combined molds and yeasts count

≤100 cfu/g

Assay

≥98%

CAS No.

128446-35-5

Molecular Formula

C42H70-nO35(C3H7O)n

Molecular Weight

1134.98 + 58n

Hydroxypropyl Beta Cyclodextrin Pharmaceutical Applications

Solubilization of Poorly Water-Soluble APIs

HP-β-CD forms inclusion complexes with lipophilic drug molecules, increasing their aqueous solubility. This property supports formulation development for compounds with low water solubility, enabling liquid dosage form preparation.

Bioavailability Enhancement

By improving drug solubility, HP-β-CD can contribute to enhanced oral bioavailability of certain APIs. Formulators may use this excipient to adjust dosage levels or improve absorption profiles.

Controlled Release and Toxicity Reduction

The cyclodextrin complex can modulate drug release kinetics. In injection formulations, it may help reduce local irritation or toxicity associated with certain active ingredients.

Delivery System Compatibility

HP-β-CD is suitable for various delivery routes, including:

Injectable formulations (intravenous, intramuscular)

Mucosal delivery systems (nasal, rectal, ocular)

Transdermal delivery systems

Targeted drug delivery carriers for lipophilic agents

Protein protection and stabilization applications

HP-β-CD Manufacturing and Regulatory Compliance

Production Facility

Manufacturing operations take place in a 2,000 m² dedicated cleanroom facility operated under GMP guidelines. Production processes follow established SOPs with documented batch records.

Regulatory Registrations

FDA DMF Registration: #030168

FDA Establishment Identifier (FEI): 3011680310

DUNS Number: 548171477

Facility Address: Boxing Economic Development Zone, Binzhou, Shandong 256500, China

Pharmacopeia Compliance

The product meets the requirements of current USP, EP, and CP monographs for Hydroxypropyl Beta Cyclodextrin. Each batch is tested against the specified quality parameters before release.

Packaging, Storage and Supply for HP-β-CD

Packaging Options

10 kg per bag

20 kg per bag

Inner packaging: PE bag enclosed in aluminum foil bag

Outer packaging: Carton or fiber drum

Custom labeling available upon request

Storage Conditions

Shelf life: 36 months in unopened original packaging

Recommended storage: Room temperature, sealed containers, dry conditions

Post-expiry use requires requalification testing for intended application

Supply and Delivery

Inventory levels maintained for standard orders

Lead time: 1-3 working days for stocked items

Shipping terms available: FOB, CFR, CIF, DDU

Loading location: Binzhou, Shandong, China

Air freight and express delivery options available for high-value orders

FAQ

Can samples be evaluated before placing orders?

Yes, sample quantities are available for quality evaluation. Batch production material maintains consistency with sample specifications, verified through batch analysis reports.

Is a Certificate of Analysis provided with each shipment?

Yes, each shipment includes a product analysis report detailing test results against the specified quality parameters. Reports cover all items listed in the product specification.

Are volume-based pricing structures available?

Pricing varies according to order quantity. Commercial procurement teams may contact the sales department for specific quotation based on required volume and delivery terms.

What is the minimum order quantity for HP-β-CD injection grade?

Standard packaging units are 10 kg and 20 kg. For initial evaluation orders, smaller quantities may be arranged through the sales team. Enterprise customers with specific packaging or formulation requirements should discuss customization options directly.

Previous: 
Next: 

Tel

+86-531-6310-3628

Address

Yinfeng International Biocity A7, Jinan, Shandong, China

ABOUT US

Jinan Xinzhiyuan Biotechnology Co., Ltd. is a high-tech enterprise specializing in new materials, including pharmaceutical excipients and cosmetic ingredients, relying on the support of Shandong Binzhou Zhiyuan Biotechnology Co., Ltd.

QUICK LINKS

PRODUCT CATEGORY

CONTACT US

Copyright © 2025 Jinan Xinzhiyuan Biotechnology Co., Ltd. All Rights Reserved.|SitemapPrivacy Policy